Da nyreudskillelsen af imatinib er negligeabel, forventes det ikke, at ubundet imatinib- clearance falder hos patienter med nyreinsufficiens.
Since the renal clearance of imatinib is negligible, a decrease in free imatinib clearance is not expected in patients with renal insufficiency.